Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infants.

[1]  R. Wijffels,et al.  Next Generation Inactivated Polio Vaccine Manufacturing to Support Post Polio-Eradication Biosafety Goals , 2013, PloS one.

[2]  Hiromasa Okayasu,et al.  Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adults. , 2013, Vaccine.

[3]  K. Ueda,et al.  Phase II and III Clinical Studies of Diphtheria-Tetanus-Acellular Pertussis Vaccine Containing Inactivated Polio Vaccine Derived from Sabin Strains (DTaP-sIPV). , 2013, The Journal of infectious diseases.

[4]  T. Vedvick,et al.  Antigen sparing with adjuvanted inactivated polio vaccine based on Sabin strains. , 2013, Vaccine.

[5]  Changgui Li,et al.  Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: a phase II, randomized, positive-controlled trial. , 2012, The Journal of infectious diseases.

[6]  W. Bakker,et al.  Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV. , 2011, Vaccine.

[7]  W. Bakker,et al.  Clinical development of a novel inactivated poliomyelitis vaccine based on attenuated Sabin poliovirus strains , 2011, Expert review of vaccines.

[8]  W. Bakker,et al.  Characterization and standardization of Sabin based inactivated polio vaccine: proposal for a new antigen unit for inactivated polio vaccines. , 2011, Vaccine.

[9]  Who Publication.  Polio vaccines and polio immunization in the pre-eradication era: WHO position paper--recommendations. , 2010, Vaccine.

[10]  E. Ruitenberg,et al.  The global introduction of inactivated polio vaccine can circumvent the oral polio vaccine paradox. , 2010, Vaccine.

[11]  S. Plotkin.  Correlates of Protection Induced by Vaccination , 2010, Clinical and Vaccine Immunology.

[12]  P. Minor.  Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication. , 2009, Vaccine.

[13]  K. Chumakov,et al.  New generation of inactivated poliovirus vaccines for universal immunization after eradication of poliomyelitis. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  B. Simizu,et al.  Antigenic characterization of a formalin-inactivated poliovirus vaccine derived from live-attenuated Sabin strains. , 2007, Vaccine.

[15]  Kimberly M Thompson,et al.  Risk Management in a Polio‐Free World , 2006, Risk analysis : an official publication of the Society for Risk Analysis.

[16]  G. Kersten,et al.  Technology transfer of Sabin-IPV to new developing country markets. , 2006, Biologicals : journal of the International Association of Biological Standardization.

[17]  B. Simizu,et al.  Development of inactivated poliovirus vaccine derived from Sabin strains. , 2006, Biologicals : journal of the International Association of Biological Standardization.

[18]  D. Heymann,et al.  A global call for new polio vaccines , 2005, Nature.

[19]  A. Ivshina,et al.  Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy. , 2004, The Journal of infectious diseases.

[20]  M. Miyazawa,et al.  Progress with inactivated poliovirus vaccines derived from the Sabin strains. , 2001, Developments in biologicals.

[21]  C. Beuvery,et al.  Antigenic and immunogenic properties of inactivated polio vaccine made from Sabin strains. , 1999, Vaccine.

[22]  A. Heath,et al.  A WHO collaborative study of immunogenicity assays of inactivated poliovirus vaccines. , 1995, Biologicals : journal of the International Association of Biological Standardization.

[23]  G. vanSteenis,et al.  Potency testing of killed polio vaccine in rats. , 1981 .